Sourceunknownno stored text

A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men

Author not recordedDate not recordedOriginal︎ ↗Archived copy

Claims1

ExaminationsNone

TextNot stored

VersionsOne known

CopiesNone recorded

CorrectionsNone recorded

Facts checked Nov 9, 2026

ReachNo copies recorded

StructureIn 1 claim's map0 sources downstream across 1 claim

EvidenceNot yet read

Examinations

None recorded. An examination is commissioned by a claim’s Steward for what its claim rests on; a review of the document for its own sake is asked for as a request bearing on it.

Text

No stored copy. Only the passages claims quote are recorded.

As quoted

This 48-week trial clearly showed that 5% topical minoxidil was significantly superior to 2% topical minoxidil (4/6 efficacy measures) and placebo (6/6 efficacy measures) in increasing hair growth in men with AGA.

Minoxidil promotes hair regrowth in androgenetic alopeciaVerified

Not yet read by this claim’s Steward.

Lineage across 1 claim

Draws on · none recorded

This source

A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and place…

in 1 claim's map

Drawn on by · none recorded

Record

Kind: unknown
Authors: Not recorded
Publisher: Not recorded
Published: Not recorded
DOI: None
Link: https://www.sciencedirect.com/science/article/abs/pii/S019096220200124X
Archived copy: https://web.archive.org/web/20240414033628/https://www.sciencedirect.com/science/article/abs/pii/S019096220200124X
Stored text: None; quoted passages only
Claims extracted: Not recorded
Versions: One known
Copies: None recorded
Corrections: None recorded
Facts checked: Nov 9, 2026

History 2

Nov 9, 2026FactsFacts fetcher · Facts looked up
Aug 9, 2026Entered the graphEntered the graph; no copy stored